puro Antibody
puro Antibody
 lentivirus) hTERT (EF1a, Puro) lentivirus |
|||
| LVP1131-Puro | GenTarget | 1x107 IFU/ml x 200ul | 418.8 EUR |
|
Description: Premade lentivirus expressing human TERT gene under EF1a promoter, containing Puromycin marker. |
|||
 , Lentiviral particles) rtTA (Puro) , Lentiviral particles |
|||
| LVP400-Puro | GenTarget | 1x107 IFU/ml x 200ul | 484.8 EUR |
|
Description: Pre-made lentiviral particles expressing reverse tetracycline Transcriptional Activator (rtTA) under enhanced EF1a promoter with Puromycin antibioic marker, provided in DMEM medium with 10% FBS. |
|||
 Lentiviral particles ) CMV-TetR (Puro) Lentiviral particles |
|||
| LVP017-Puro | GenTarget | 1x107 IFU/ml x 200ul | 484.8 EUR |
|
Description: Pre-made lentiviral particles expressing tetracycline regulator protein (TetR) under CMV promoter, with Puromycin antibiotic marker. |
|||
 lentiviral particles) β-Lactamase (Puro) lentiviral particles |
|||
| LVP335-Puro | GenTarget | 1x107 IFU/ml x 200ul | 418.8 EUR |
|
Description: pre-made lentiviral particles expressing β-Lactamase gene. A puromycin marker was expressed under RSV promoter. Particles is provided in DMEM medium with 10% FBS and 60ug/ml of polybrene. |
|||
 Lentiviral particles ) EF1a-TetR (Puro) Lentiviral particles |
|||
| LVP459-Puro | GenTarget | 1x107 IFU/ml x 200ul | 484.8 EUR |
|
Description: Pre-made lentiviral particles expressing tetracycline regulator protein (TetR) under enhanced EF1a promoter with Puromycin antibioic marker. |
|||
 stable cells) Hela-TetR (Puro) stable cells |
|||
| SC035-Puro | GenTarget | 2 x 106 cell/ml x 1ml | 1452 EUR |
|
Description: tetracycline repressor expression Hela stable cell line with Puromycin marker |
|||
 lentivirus) LoxP GFP/RFP ColorSwitch (Puro) lentivirus |
|||
| LVP460-Puro | GenTarget | 1x107 IFU/ml x 200ul | 852 EUR |
|
Description: Pre-made lentiviral particles expressing "LoxP-GFP-stop-LoxP-RFP-Stop" cassette under suCMV promoter. It also contains a puromycin antibiotic selection marker under Rsv promoter. Virus is provided in DMEM medium with 10% FBS and 60ug/ml of polybrene. |
|||
, CMV lentiviral particles) SV40 large T-antigen (Puro), CMV lentiviral particles |
|||
| LVP016-Puro | GenTarget | 1x107 IFU/ml x 200ul | 418.8 EUR |
|
Description: Pre-made lentiviral particles expressing SV40 large T-antigen under suCMV promoter, containing puromycin marker. |
|||
, EF1a lentiviral particles) SV40 large T-antigen (Puro), EF1a lentiviral particles |
|||
| LVP557-Puro | GenTarget | 1x107 IFU/ml x 200ul | 418.8 EUR |
|
Description: Pre-made lentiviral particles expressing SV40 large T-antigen under EF1a promoter, containing puromycin marker. |
|||
 Stable Cell Line) MDA-MB-231 / GFP (Puro) Stable Cell Line |
|||
| SC040-Puro | GenTarget | 2 x 106 cell/ml x 1ml | 1452 EUR |
|
Description: GFP expression stable cell line in MDA-MB-231 cells with Puromycin resistance |
|||
 Stable Cell Line) MDA-MB-231 / Luciferase (Puro) Stable Cell Line |
|||
| SC059-Puro | GenTarget | 2 x 106 cell/ml x 1ml | 1800 EUR |
|
Description: Luciferase (firefly) expression stable cell line in MDA-MB-231 cells with Puromycin resistance |
|||
) Color Switch, CRE report cell line: HEK293-loxP-GFP-RFP (Puro) |
|||
| SC018-Puro | GenTarget | 2x10E6 cell/ml x1ml | 5280 EUR |
|
Description: CRE reporter cell line (Puro): HEK293 cell line expressing "LoxP-GFP-stop-LoxP-RFP" cassette with Puromycin antibiotic marker |
|||
 pBABE-Puro Retroviral Vector |
|||
| RTV-001-PURO | Cell Biolabs | 10 ?g | 679.2 EUR |
|
Description: Use this construct to clone your gene for downstream recombinant retroviral packaging |
|||
) CMV Control lentiviral particles (Puro) |
|||
| CMV-Null-Puro | GenTarget | 1 x107 IFU/ml x 200ul | 418.8 EUR |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Puromycin marker under RSV promoter. |
|||
) EF1a Control lentiviral particles (Puro) |
|||
| EF1a-Null-Puro | GenTarget | 1 x107 IFU/ml x 200ul | 418.8 EUR |
|
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Puromycin marker under RSV promoter. |
|||
 lentivirus in PBS) hTERT (CMV, Puro) lentivirus in PBS |
|||
| LVP1130-Puro-PBS | GenTarget | 1x108 IFU/ml x 200ul | 852 EUR |
|
Description: Concentrated lentivirus in PBS, expressing human TERT gene under suCMV promoter, containing Puromycin marker. |
|||
 lentivirus in PBS) hTERT (EF1a, Puro) lentivirus in PBS |
|||
| LVP1131-Puro-PBS | GenTarget | 1x108 IFU/ml x 200ul | 852 EUR |
|
Description: Concentrated lentivirus in PBS, expressing human TERT gene under EF1a promoter, containing Puromycin marker. |
|||
 in PBS, Lentiviral particles) rtTA (Puro) in PBS, Lentiviral particles |
|||
| LVP400-Puro-PBS | GenTarget | 5x107 IFU/ml x 200ul | 608.4 EUR |
|
Description: Pre-made lentiviral particles expressing reverse tetracycline Transcriptional Activator (rtTA) under enhanced EF1a promoter with Puromycin antibioic marker. |
|||
 Stable Cell Line) A549 / Cas9 (Puro) Stable Cell Line |
|||
| SC043-Cas9-Puro | GenTarget | 2 x 106 cell/ml x 1ml | 1269.6 EUR |
|
Description: Cas9 expression stable cell line with Puromycin marker in A549 human lung cancer cells. |
|||
 Lentiviral particles in PBS) CMV-TetR (Puro) Lentiviral particles in PBS |
|||
| LVP017-Puro-PBS | GenTarget | 5x107 IFU/ml x 200ul | 608.4 EUR |
|
Description: Pre-made lentiviral particles expressing tetracycline regulator protein (TetR) under CMV promoter, with Puromycin antibiotic marker. Particles pellet was re-suspended in PBS solution. |
|||
 Lentiviral particles in PBS) EF1a-TetR (Puro) Lentiviral particles in PBS |
|||
| LVP459-Puro-PBS | GenTarget | 5x107 IFU/ml x 200ul | 608.4 EUR |
|
Description: Pre-made lentiviral particles expressing tetracycline regulator protein (TetR) under enhanced EF1a promoter with Puromycin antibioic marker. Particles was pellet down and re-suspended in PBS solution. |
|||
 lentivirus (concentrated)) LoxP GFP/RFP ColorSwitch (Puro) lentivirus (concentrated) |
|||
| LVP460-Puro-PBS | GenTarget | 5x107 IFU/ml x 200ul | 1034.4 EUR |
|
Description: Pre-made lentiviral particles expressing "LoxP-GFP-stop-LoxP-RFP-Stop" cassette under suCMV promoter. It also contains a puromycin antibiotic selection marker under Rsv promoter. Virus was provied in PBS solution. |
|||
 in PBS, CMV lentiviral particles) SV40 large T-antigen (Puro) in PBS, CMV lentiviral particles |
|||
| LVP016-Puro-PBS | GenTarget | 5x107 IFU/ml x 200ul | 852 EUR |
|
Description: Pre-made lentiviral particles expressing SV40 large T-antigen under suCMV promoter, containing puromycin marker, provided in PBS solution. |
|||
 in PBS, EF1a lentiviral particles) SV40 large T-antigen (Puro) in PBS, EF1a lentiviral particles |
|||
| LVP557-Puro-PBS | GenTarget | 5x107 IFU/ml x 200ul | 852 EUR |
|
Description: Pre-made lentiviral particles expressing SV40 large T-antigen under EF1a promoter, containing puromycin marker, provided in PBS solution. |
|||
 in PBS) CMV Control lentiviral particles (Puro) in PBS |
|||
| CMV-Null-Puro-PBS | GenTarget | 1 x108 IFU/ml x 200ul | 852 EUR |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Puromycin marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
 in PBS) EF1a Control lentiviral particles (Puro) in PBS |
|||
| EF1a-Null-Puro-PBS | GenTarget | 1 x108 IFU/ml x 200ul | 852 EUR |
|
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Puromycin marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
, HEK293 stable cells (Puromycin)) luciferase (firefly), HEK293 stable cells (Puromycin) |
|||
| SC002-Puro | GenTarget | 2 x 106 cell/ml x 1ml | 843.6 EUR |
|
Description: Luciferase (firefry) stable cell line with Puromycin marker. |
|||
 CRE stable cells with Puromycin marker |
|||
| SC004-Puro | GenTarget | 2 x 106 cell/ml x 1ml | 1365.6 EUR |
|
Description: CRE recombinase stable cell line with Puromycin resistance |
|||
, HEK293 stable cells (Puromycin)) luciferase (Renilla), HEK293 stable cells (Puromycin) |
|||
| SC020-Puro | GenTarget | 2 x 106 cell/ml x 1ml | 1191.6 EUR |
|
Description: Luciferase (Renilla) stable cell line with Puromycin marker. |
|||
 and CRE co-expression stable cell line (puromycin)) Luciferase (firefly) and CRE co-expression stable cell line (puromycin) |
|||
| SC021-Puro | GenTarget | 2 x 106 cell/ml x 1ml | 1452 EUR |
|
Description: Luciferase (firefly) and CRE recombinase co-expression stable cell line with Puromycin marker. |
|||
 Hela-RFP stable cells |
|||
| SC031-Puro | GenTarget | 2 x 106 cell/ml x 1ml | 930 EUR |
|
Description: RFP expression stable cell line in Hela cells with Puromycin marker. |
|||
, Hela stable cells (Puromycin)) Luciferase (firefly), Hela stable cells (Puromycin) |
|||
| SC032-Puro | GenTarget | 2 x 106 cell/ml x 1ml | 1452 EUR |
|
Description: Luciferase (firefry) expression stable cell line in Hela cells with Puromycin marker. |
|||
) Hela-GFP stable cells (Puromycin) |
|||
| SC034-Puro | GenTarget | 2 x 106 cell/ml x 1ml | 930 EUR |
|
Description: GFP expression stable cell line in Hela cells with Puromycin marker. |
|||
) CHO-GFP stable cells (Puromycin) |
|||
| SC039-Puro | GenTarget | 2 x 106 cell/ml x 1ml | 930 EUR |
|
Description: GFP expression stable cells in CHO cell line with Puromycin resistance |
|||
 CFP-Null fusion control lentiviral particles |
|||
| Null-C--(Puro) | GenTarget | 1x107 IFU/ml x 200ul | 418.8 EUR |
|
Description: Pre-made CFP-Null fusion Control lentivirus containing puromycin marker. CFP fusioned with a non-targeting Null sequence for evenly fluorescent signal distribution. Virus contains a Puromycin selection marker. |
|||
 GFP-Null fusion control lentiviral particles |
|||
| Null-G-(Puro) | GenTarget | 1x107 IFU/ml x 200ul | 418.8 EUR |
|
Description: Pre-made GFP-Null fusion Control lentivirus containing puromycin marker. GFP fusioned with a non-targeting Null sequence for evenly fluorescent signal distribution. Virus contains a Puromycin selection marker. |
|||
 RFP-Null fusion control lentiviral particles |
|||
| Null-R--(Puro) | GenTarget | 1x107 IFU/ml x 200ul | 418.8 EUR |
|
Description: Pre-made RFP-Null fusion Control lentivirus containing puromycin marker. RFP fusioned with a non-targeting Null sequence for evenly fluorescent signal distribution.Virus contains a Puromycin selection marker. |
|||
-(Puromycin) lentivirus) shRNA-H1 (Neg)-(Puromycin) lentivirus |
|||
| H1(shRNA-Ctr)-Puro | GenTarget | 1 x107 IFU/ml x 200ul | 418.8 EUR |
|
Description: Pre-made optional inducible lentiviral shRNA expression particles under human H1 promoter, containing a hairpin insert that should not knockdown any known human or mouse gene. This non-targeting control serves as a negative control for shRNA knockdown experiments. It also contains a Puromycin marker under Rsv promoter. |
|||
-(Puromycin) lentivirus) shRNA-U6 (Neg)-(Puromycin) lentivirus |
|||
| U6(shRNA-Ctr)-Puro | GenTarget | 1 x107 IFU/ml x 200ul | 418.8 EUR |
|
Description: Pre-made lentiviral shRNA expression particles under human U6 promoter, containing a hairpin insert that should not knockdown any known human or mouse gene. This non-targeting control serves as a negative control for shRNA knockdown experiments. It also contains a Puromycin marker under Rsv promoter. |
|||
 pSuper- puro |
|||
| PVT10864 | Lifescience Market | 2 ug | 361.2 EUR |
 pB513B- Puro |
|||
| PVT10878 | Lifescience Market | 2 ug | 444 EUR |
 pT2- Puro |
|||
| PVT10884 | Lifescience Market | 2 ug | 361.2 EUR |
 pLentiGuide- Puro |
|||
| PVT10916 | Lifescience Market | 2 ug | 361.2 EUR |
 pespCas9- Puro |
|||
| PVT10952 | Lifescience Market | 2 ug | 361.2 EUR |
 pBABE- Puro |
|||
| PVT11054 | Lifescience Market | 2 ug | 361.2 EUR |
 pMXS-Puro |
|||
| PVT14044 | Lifescience Market | 2 ug | 843.6 EUR |
 pGreen- Puro- pSIH1- H1- copGFP- T2A- Puro |
|||
| PVT11116 | Lifescience Market | 2 ug | 444 EUR |
) SEAP (TetCMV, Puro) |
|||
| LVP1184 | GenTarget | 1x107 IFU/ml x 200ul | 418.8 EUR |
|
Description: Lentivirus express SEAP under optional inducible TetCMV promoter, containing puromycin selection. |
|||
) SEAP (EF1a, Puro) |
|||
| LVP1193 | GenTarget | 1x107 IFU/ml x 200ul | 418.8 EUR |
|
Description: Lentivirus express SEAP under EF1a promoter, containing puromycin selection. |
|||
) SEAP (CAG, Puro) |
|||
| LVP1202 | GenTarget | 1x107 IFU/ml x 200ul | 418.8 EUR |
|
Description: Lentivirus express SEAP under CAG promoter, containing puromycin selection. |
|||
) SEAP (Ubc, Puro) |
|||
| LVP1219 | GenTarget | 1x107 IFU/ml x 200ul | 418.8 EUR |
|
Description: Lentivirus express SEAP under Ubc promoter, containing puromycin selection. |
|||
) SEAP (mPGK, Puro) |
|||
| LVP1220 | GenTarget | 1x107 IFU/ml x 200ul | 418.8 EUR |
|
Description: Lentivirus express SEAP under mPGK promoter, containing puromycin selection. |
|||
) SEAP (ActB, Puro) |
|||
| LVP1221 | GenTarget | 1x107 IFU/ml x 200ul | 418.8 EUR |
|
Description: Lentivirus express SEAP under ActB promoter, containing puromycin selection. |
|||
, (Puro) ) Luciferase (Cypridina), (Puro) |
|||
| LVP377 | GenTarget | 1x107 IFU/ml x 200ul | 418.8 EUR |
|
Description: Pre-made lentiviral particles expressing Cypridina luciferase with Puromycin marker, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene. |
|||
 pMKO.1-puro |
|||
| PVT17663 | Lifescience Market | 2 ug | 360 EUR |
 pLVX- Puro Plasmid |
|||
| PVT2301 | Lifescience Market | 2 ug | 319.2 EUR |
 pGreen- puro Plasmid |
|||
| PVT2342 | Lifescience Market | 2 ug | 427.2 EUR |
 lentiGuide- Puro Plasmid |
|||
| PVT6316 | Lifescience Market | 2 ug | 351.6 EUR |
 pPLK/GFP+Puro- |
|||
| PVTB00678-3a | Lifescience Market | 2 ug | 427.2 EUR |
 pCAG- IRES- Puro |
|||
| PVT10733 | Lifescience Market | 2 ug | 319.2 EUR |
 pSilencer- U6- Puro |
|||
| PVT10865 | Lifescience Market | 2 ug | 361.2 EUR |
 Lenti- Cas9- Puro |
|||
| PVT10981 | Lifescience Market | 2 ug | 319.2 EUR |
 Tet- pLKO- Puro |
|||
| PVT11005 | Lifescience Market | 2 ug | 361.2 EUR |
 pLKO.1- Puro |
|||
| PVT11106 | Lifescience Market | 2 ug | 361.2 EUR |
 pLVX- TetOne- Puro |
|||
| PVT11126 | Lifescience Market | 2 ug | 1275.6 EUR |
 pSIH1- ControlshRNA- Puro |
|||
| PVT11395 | Lifescience Market | 2 ug | 361.2 EUR |
 pGL4.84[hRlucCP Puro] |
|||
| PVT13579 | Lifescience Market | 2 ug | 843.6 EUR |
 pGL4.20[luc2 Puro] |
|||
| PVT14038 | Lifescience Market | 2 ug | 843.6 EUR |
 piggyBac-133CAR_opt-puro |
|||
| PVT14039 | Lifescience Market | 2 ug | 1093.2 EUR |
) lentiSAM v2 (Puro) |
|||
| PVT14644 | Lifescience Market | 2 ug | 843.6 EUR |
 AIO-Puro Plasmid |
|||
| PVT14777 | Lifescience Market | 2 ug | 444 EUR |
 pLenti- puro- ARID1A |
|||
| PVT10190 | Lifescience Market | 2 ug | 361.2 EUR |